tiprankstipranks
Advertisement
Advertisement
Renalytix CEO Increases Stake Amid Expansion of Kidney Disease Test
PremiumCompany AnnouncementsRenalytix CEO Increases Stake Amid Expansion of Kidney Disease Test
2M ago
Renalytix Eyes Revenue Growth as Kidney Diagnostic Expands U.S. Footprint
Premium
Company Announcements
Renalytix Eyes Revenue Growth as Kidney Diagnostic Expands U.S. Footprint
2M ago
Renalytix Adds Three U.S. Kidney Care Integrations and Deepens Tempus AI Collaboration
Premium
Company Announcements
Renalytix Adds Three U.S. Kidney Care Integrations and Deepens Tempus AI Collaboration
3M ago
Renalytix Publishes 2025 Annual Report and Expands Kidney Disease Test Deployment
PremiumCompany AnnouncementsRenalytix Publishes 2025 Annual Report and Expands Kidney Disease Test Deployment
5M ago
Renalytix Reports Strong Fiscal 2025 Results and Strategic Expansion
Premium
Company Announcements
Renalytix Reports Strong Fiscal 2025 Results and Strategic Expansion
5M ago
Renalytix Secures £860k in R&D Tax Credits
Premium
Company Announcements
Renalytix Secures £860k in R&D Tax Credits
6M ago
Renalytix Secures Additional Institutional Investment to Bolster U.S. Market Expansion
PremiumCompany AnnouncementsRenalytix Secures Additional Institutional Investment to Bolster U.S. Market Expansion
7M ago
Renalytix Projects Revenue Growth with Tempus Collaboration
Premium
Company Announcements
Renalytix Projects Revenue Growth with Tempus Collaboration
7M ago
Renalytix Secures £5.20 Million for Growth and Collaboration
Premium
Company Announcements
Renalytix Secures £5.20 Million for Growth and Collaboration
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100